Marie Shin, DPM
Primary Podiatric Medicine · Garden Grove, CANPI 1275824971
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $508 of the $732 with a category attached, or 69.4%. 9 manufacturers reported payments, led by Treace Medical Concepts, Inc. at 31.4% of the total. Reporting peaked in 2019 at $324 and has fallen 92.4% since, to $25 in 2024. That places this record below the midpoint for primary podiatric medicine clinicians in CA, where the typical reported total is $887.
Across 10 payments — averaging $73.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Treace Medical Concepts, Inc.$230
- Novo Nordisk$125
- Johnson & Johnson$120
- Organogenesis Inc.$99
- Crossroads Extremity Systems, LLC$68
- Tactile Systems Technology Inc$36
- plus $53 from 3 others
What the payments were for
- Travel & lodging$22431%
- Food & beverage$50869%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Treace Medical Concepts, Inc. | 2 | $230 |
| Novo Nordisk | 1 | $125 |
| Johnson & Johnson | 1 | $120 |
| Organogenesis Inc. | 1 | $99 |
| Crossroads Extremity Systems, LLC | 1 | $68 |
| Tactile Systems Technology Inc | 1 | $36 |
| Hologic Sales And Service, LLC | 1 | $25 |
| Amgen | 1 | $14 |
| Pfizer | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$732 in reported general payments places this provider in the 40th percentile of 59 primary podiatric medicine providers in California.
See all primary podiatric medicine providers in California →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| CiclopiroxCiclopirox Olamine | 700 | $14,016 |
| Halobetasol Propionate | 50 | $2,352 |
| Gentamicin Sulfate | 38 | $1,951 |
| Diclofenac Sodium | 77 | $1,195 |
| Mupirocin | 156 | $882 |
| Silver Sulfadiazine | 48 | $415 |
| SsdSilver Sulfadiazine | 40 | $401 |
| Gabapentin | 74 | $275 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 14 | $253 |
| Methylprednisolone | 31 | $185 |
| Meloxicam | 109 | $128 |
| Clindamycin Hcl | 28 | $125 |
| Levofloxacin | 35 | $56 |
| Naproxen | 22 | $40 |
Paid to pharmacies, not to this prescriber.
Other primary podiatric medicine in Garden Grove
- Duc NguyenGarden Grove$1K
- James WangLos Angeles$250K
- Adam ShapiroUpland$21K
- Ali GhorbanifarajzadehBakersfield$17K
- Abid ChaudhryArleta$11K
- Matthew GarrisonSacramento$7K
- Linh HuynhTurlock$7K
- Yvette CanabaSantee$5K
- David KhakshoorLos Angeles$4K
- Katrina SergeevaVista$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.